MetaCap

Rein Therapeutics (RNTX) News

NASDAQ: RNTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.3369-0.0308 (-8.38%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

RNTX news summary

We found 2 recent headlines mentioning Rein Therapeutics (RNTX): 2 in the past week and 2 in the past 30 days, most often from Nasdaq, GlobeNewswire. RNTX is making an outsized move today, down 8.38% at $0.3369, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Rein Therapeutics Announces Preliminary Blinded Phase 2 RENEW Data and Reports Third Quarter 2026 Financial Results", was published by Nasdaq on Nov 16, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Rein Therapeutics headlines

Compare RNTX